Francisco Salgado

Universitat de Barcelona, Hospital Clínic de Barcelona

Papers

2

Total Citations

6

H-Index

2

About

Francisco Salgado is a pioneering hepatopancreatobiliary surgeon whose research focuses on advancing minimally invasive techniques for complex pancreatic surgeries, particularly robotic pancreaticoduodenectomy (RPD). His major contributions center on improving surgical outcomes in high-risk patients, notably through the innovative use of biodegradable biliary stents to prevent biliary fistulas—a complication occurring in 3–8% of pancreaticoduodenectomy cases. His 2024 study on high-risk biliary anastomosis during RPD demonstrated the efficacy of these stents in patients with bile ducts ≤5 mm, a critical risk factor, earning 4 citations. Salgado also developed the PD-ROBOSCORE, a risk stratification tool that identifies factors increasing surgical difficulty, and his 2025 work investigated whether RPD is non-inferior to open pancreaticoduodenectomy in high-score patients, accumulating 2 citations. By addressing technical challenges and reducing postoperative complications, Salgado’s research directly enhances patient safety and expands the applicability of robotic surgery. His work is instrumental for surgeons and trainees seeking to master complex robotic procedures, offering evidence-based strategies to mitigate risks in the most demanding cases.

Research Focus

Key Achievements

2
H-Index
2
Papers
6
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
High-Risk Biliary Anastomosis During Robotic Pancreaticoduodenectomy: Initial Experience with Biodegradable Biliary Stent
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Universitat de Barcelona, Hospital Clínic de Barcelona

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago